Advantage: Where AI Creates Moats and Where It Does Not

Why this module exists

If everyone can buy the same capability from the same providers on the same day, capability is not advantage. It is table stakes arriving on a schedule.

This is the module where the course stops being about deployment and starts being about whether any of it makes you money that a competitor cannot also make. The answer is yes — but almost never at the layer where the investment is being announced.

8.1 Capability commoditises

Jay Barney's resource-based view gives the standard test for a sustainable advantage. A resource must be valuable, rare, inimitable and non-substitutable. Apply it honestly to "we use a frontier model":

Test	"We use a frontier model"
Valuable?	Yes
Rare?	No — available to anyone with a credit card
Inimitable?	No — copied in an afternoon
Non-substitutable?	No — three providers and a growing open-weight field

One out of four. The model layer fails the test comprehensively, and the economics from Module 1 explain why: at a fixed quality bar, price falls by roughly an order of magnitude a year. Anything whose advantage rests on access to capability is standing on the fastest-deflating asset in the stack.

This should be liberating rather than deflating. It means you do not have to win the model race, and the enormous capital being spent there is being spent on your behalf by other people.

8.2 What actually survives the test

Five categories pass, and each is something you already own or can build.

Proprietary process knowledge, in a usable form. How your business actually decides — which claims are worth appealing, which customers get flexibility, what a good technician's note contains. This exists today in people's heads, which is why it is inimitable and also why it is inaccessible. The act of writing it down so that a system can use it is the value-creating step, and it is not a technology project.

Records of past decisions. A decision archive — what was approved, on what evidence, and what happened next — is rare, valuable and hard to copy, because it can only be accumulated in real time. Competitors cannot buy your history. Note that Module 5's traces are precisely this, produced as a by-product of running the system.

Distribution and installed base. Unchanged by AI, and increasingly the decisive factor: capability arriving equally to everyone raises the relative value of already having the customers.

Integration depth and switching costs. A system woven into a customer's workflow, holding their configuration and history, is defensible in a way that a clever feature is not. This cuts both ways — it is also the reason Module 7 spends so long on your own exit terms.

Regulatory position. Certification, approvals, and demonstrated compliance are rare and slow to imitate by construction. In regulated sectors, Module 6's control set is not a cost centre; it is a barrier to entry that you are permitted to build.

And the one everybody claims: data. Data is an advantage only under specific conditions, which is why the next section is about telling the difference.

The left column arrives on a schedule for everyone. Only the right column is yours.

8.3 A flywheel is not a data lake

Most claimed data advantages are inventories. A flywheel has four properties, and all four must hold:

The data is generated by your operation and cannot be purchased.
Using the product produces more of it — the loop closes automatically rather than through a project.
More of it makes the product measurably better — with a demonstrated relationship, not an assumed one.
Better product attracts more usage, which returns to step 2.

Break any link and you have a large, expensive archive. The most commonly broken link is the third: organisations accumulate volume long past the point where additional volume improves anything. Ten years of tickets is not ten times better than one year; it is one year of signal and nine years of drift.

Two diagnostic questions:

"What would we do differently with ten times the data?" If the answer is vague, you do not have a flywheel.
"Does using the product create labelled examples automatically?" The Module 5 trace — human edits and overrides captured as a by-product — is the cheapest flywheel available, and most organisations discard it.

8.4 Industry structure

Porter's five forces still work; AI changes their inputs. Run your industry through this table rather than reasoning from the technology.

Force	Where AI weakens your position	Where it strengthens it
Threat of entry	Content, analysis, support and design work get cheap — small entrants look bigger	Regulated deployment, integration and demonstrated trust get more expensive to replicate
Supplier power	A new and concentrated dependency on model providers	Multiple providers and open-weight alternatives, if you keep the model swappable
Buyer power	Customers can evaluate and switch more cheaply	Deeper workflow integration raises their switching cost
Substitutes	Services previously requiring expertise become products	Bundled judgement and accountability are harder to substitute
Rivalry	Feature parity arrives faster; differentiation decays	Operating cost advantages compound if you actually redesign the work

The row that catches people is supplier power. Adopting AI at scale creates a dependency on a small number of providers whose pricing, model behaviour and terms can change with limited notice. Module 7's swappability and exit terms are a competitive instrument, not an administrative detail.

The row that matters most is the last one. Feature parity arrives quickly; operating-model change does not. McKinsey's finding that workflow redesign is the strongest correlate of profit impact is a strategy finding, not an implementation one: the durable gap is between organisations that redesigned the work and organisations that added a tool to the existing work.

8.5 Where to lead and where to follow

Most organisations get this exactly backwards. They lead where capability is commoditising — a chat assistant, a summarisation feature, a copilot in the product — and follow where advantage compounds, because that part is slow, political and unglamorous.

A rule to invert it:

Lead where the asset compounds and cannot be bought. Follow where the capability arrives on a schedule.

Lead here	Follow here
Capturing your process knowledge in usable form	The newest model
Building the decision record and evaluation set	Feature parity in the UI
Governance and certification in regulated markets	Generic assistant experiences
Redesigning the workflow around a new cost structure	Infrastructure others will commoditise

Following is not passivity. It is a decision to spend the same money on the thing that will still be yours in three years.

8.6 Reading a competitor's move

When a rival announces something, apply Module 2's ladder before your board applies its adrenaline.

What rung is this? A press release is rung one. A named customer with a number is rung three.
What is the bill of materials? Module 3's discipline, applied from outside: how much of what they announced is plumbing they already had?
Which layer did they invest in? If it is the commoditising layer, their advantage has an expiry date. If they are capturing process knowledge or building a regulatory position, that is the serious signal.
Would their claim survive our five questions? Often the announcement describes a use case that fails Question 5 on volume, which tells you it is positioning.

The most common correct conclusion is: this is a signalling move, and the appropriate response is not to match it. The FactSet finding from Module 2 — that the market rewards the word — means you should expect a high ratio of announcement to deployment, and should not let that ratio set your capital allocation.

Vantis Diagnostics — where the moat actually is

Vantis's board asks the right question in the wrong form: "Will AI give us an advantage over the other labs?"

Running the VRIN test across the programme:

Asset	Valuable	Rare	Inimitable	Verdict
Access to a frontier model	Yes	No	No	Table stakes
The denials workflow itself	Yes	Partly	No — buildable in a quarter	Cost advantage, decaying
The labelled denial corpus — 18 months of narratives clustered and validated by billers	Yes	Yes	Yes — accumulated in real time	Advantage
The payer-specific appeal knowledge — which arguments overturn which denials at which payer	Yes	Yes	Yes	Advantage
AI Act and HIPAA control set, certified	Yes	Yes	Slow to copy	Barrier to entry
Clinician relationships	Yes	Yes	Yes	Unchanged, and now cheaper to serve

The finding is uncomfortable and correct: the workflow is not the moat. The corpus and the payer knowledge it produces are. Any competitor can buy the same drafting capability next quarter. None of them can buy eighteen months of Vantis billers' judgement about what actually overturns a denial at a specific payer.

Three decisions follow immediately:

The evaluation set and trace archive stay in Vantis systems. This turns Module 7's exit clause from an administrative preference into a strategic requirement.
The flywheel is deliberately closed. Every biller override is captured as a labelled example — the loop that was previously a discarded by-product.
The compliance work is reframed. The control set was on the cost side of the business case. It moves to the advantage side: in a market where competitors must also meet HIPAA and, in Europe, the AI Act, being the lab that can already demonstrate conformity is a commercial asset with a sales cycle attached.

And one deliberate non-decision: Vantis will not build its own model. That layer is commoditising by an order of magnitude a year, and every euro spent there is a euro not spent on the corpus.

Exercise — Write your advantage thesis

Time: 60 minutes. Produces the artefact for this module.

One page. Four parts.

The asset. Name the specific thing AI makes more valuable in your business. Not a capability you can buy — an asset you have or can accumulate. Run it through the four VRIN tests in writing.
The mechanism. How does it compound? Where does the loop close, and what would break it?
The moat. Why can a well-funded competitor not have this within eighteen months? If the honest answer is that they could, say so — that is a finding, and it should redirect your investment.
The falsification clause. What evidence, observed within a year, would prove this thesis wrong? Name the observation and the date you will check.

Part four is what makes it a thesis rather than a hope, and it is the part most likely to be omitted. It is also the top band of the capstone rubric's evidence dimension.

Self-check

Apply the VRIN test to the single largest AI investment currently proposed in your organisation. What does it score?
Your team claims a data advantage. Which of the four flywheel conditions is weakest, and what evidence would settle it?
In your industry, name one entry barrier AI lowers and one it raises.
Where is your organisation currently leading that it should be following?
What would have to be true, within twelve months, for your advantage thesis to be wrong?